Renaissance Technologies’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.1K | Buy |
150,100
+26,000
| +21% | +$15.6K | ﹤0.01% | 3319 |
|
|
2025
Q1 | $33.5K | Sell |
124,100
-40,413
| -25% | -$10.9K | ﹤0.01% | 3329 |
|
|
2024
Q4 | $85.5K | Buy |
164,513
+138,625
| +535% | +$72.1K | ﹤0.01% | 3307 |
|
|
2024
Q3 | $83.9K | Sell |
25,888
-62,887
| -71% | -$204K | ﹤0.01% | 3283 |
|
|
2024
Q2 | $266K | Buy |
88,775
+53,767
| +154% | +$161K | ﹤0.01% | 2953 |
|
|
2024
Q1 | $163K | Sell |
35,008
-111,881
| -76% | -$521K | ﹤0.01% | 3273 |
|
|
2023
Q4 | $608K | Buy |
146,889
+81,614
| +125% | +$338K | ﹤0.01% | 2697 |
|
|
2023
Q3 | $196K | Sell |
65,275
-67,497
| -51% | -$203K | ﹤0.01% | 3098 |
|
|
2023
Q2 | $327K | Sell |
132,772
-180,403
| -58% | -$444K | ﹤0.01% | 3091 |
|
|
2023
Q1 | $708K | Buy |
313,175
+95,365
| +44% | +$216K | ﹤0.01% | 2686 |
|
|
2022
Q4 | $760K | Buy |
+217,810
| New | +$760K | ﹤0.01% | 2690 |
|
|
2022
Q1 | – | Sell |
-14,400
| Closed | -$324K | – | 4395 |
|
|
2021
Q4 | $324K | Sell |
14,400
-1,100
| -7% | -$24.8K | ﹤0.01% | 3310 |
|
|
2021
Q3 | $406K | Buy |
+15,500
| New | +$406K | ﹤0.01% | 2967 |
|